Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24349833)

1.

Analysis of 30 patients with persistent or recurrent squamous cell carcinoma of the cervix within one year after concurrent chemoradiotherapy.

Liu SP, Yang JX, Cao DY, Shen K.

Cancer Biol Med. 2013 Dec;10(4):227-31. doi: 10.7497/j.issn.2095-3941.2013.04.007.

2.

Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: A single-institution study.

Kim JH, Lee YS, Chung YS, Jang YJ, Kim SB, Lee SW, Lee BJ.

Acta Otolaryngol. 2015 Jun 25:1-7. [Epub ahead of print]

PMID:
26112831
3.

[Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].

Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.

Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):131-6. Chinese.

PMID:
25877611
4.
5.

The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.

Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.

PLoS One. 2015 Apr 10;10(4):e0122361. doi: 10.1371/journal.pone.0122361. eCollection 2015.

6.

Clinical characteristics of non-squamous cell carcinoma of the vagina.

Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Umayahara K, Takeshima N.

Int J Gynecol Cancer. 2015 Feb;25(2):320-4. doi: 10.1097/IGC.0000000000000351.

PMID:
25594143
7.

Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation.

Kim HW, Kim JH, Lee IJ, Kim JW, Lee YC, Lee CG, Park JJ, Youn YH, Park H.

Digestion. 2014;90(4):254-60. doi: 10.1159/000368983. Epub 2014 Dec 19.

PMID:
25531173
8.

Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.

Chen IH, Liao CT, Wang HM, Huang JJ, Kang CJ, Huang SF.

PLoS One. 2014 Jul 25;9(7):e103265. doi: 10.1371/journal.pone.0103265. eCollection 2014.

9.

Effects of chemotherapy on patients with recurrent cervical cancer previously treated with concurrent chemoradiotherapy: a retrospective multicenter survey in Japan.

Tokunaga H, Nakanishi T, Iwata T, Aoki D, Saito T, Nagase S, Takahashi F, Yaegashi N, Watanabe Y.

Int J Clin Oncol. 2015 Jun;20(3):561-5. doi: 10.1007/s10147-014-0728-9. Epub 2014 Jul 16.

PMID:
25022787
10.

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice.

Shimura K, Mabuchi S, Yokoi T, Sasano T, Sawada K, Hamasaki T, Kimura T.

J Gynecol Oncol. 2013 Oct;24(4):321-9. doi: 10.3802/jgo.2013.24.4.321. Epub 2013 Oct 2.

11.

Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy.

Kawaguchi R, Furukawa N, Kobayashi H, Asakawa I.

J Gynecol Oncol. 2013 Oct;24(4):313-20. doi: 10.3802/jgo.2013.24.4.313. Epub 2013 Oct 2.

12.

Prognostic value of different patterns of squamous cell carcinoma antigen level for the recurrent cervical cancer.

Jeong BK, Huh SJ, Choi DH, Park W, Bae DS, Kim BG.

Cancer Res Treat. 2013 Mar;45(1):48-54. doi: 10.4143/crt.2013.45.1.48. Epub 2013 Mar 31.

13.

Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?

Park G, Lee SW, Kim SY, Nam SY, Choi SH, Kim SB, Roh JL, Yoon DH, Kim SS, Park JH, Kim YS, Yoon SM, Song SY, Kim JH, Choi EK, DO Ahn S.

Anticancer Res. 2013 Mar;33(3):1237-43.

PMID:
23482808
14.

Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.

Zhang W, Dou H, Lam C, Liu J, Zhou J, Liu Y, Wang X.

Tumour Biol. 2013 Jun;34(3):1729-36. doi: 10.1007/s13277-013-0710-6. Epub 2013 Feb 23.

PMID:
23436047
15.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
16.

Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study.

Li SW, Wang H, Liu ML, Zhang HB, Xiang YQ, Lv X, Xia WX, Zeng MS, Mai HQ, Hong MH, Guo X.

Med Oncol. 2013 Mar;30(1):322. doi: 10.1007/s12032-012-0322-9. Epub 2012 Dec 15.

PMID:
23254962
17.

The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix.

Jeong BK, Choi DH, Huh SJ, Park W, Bae DS, Kim BG.

Radiat Oncol J. 2011 Sep;29(3):191-8. doi: 10.3857/roj.2011.29.3.191. Epub 2011 Sep 30.

18.

[Clinical analysis of the recurrence of early stage bulky cervical carcinoma].

Hu JL, Wu LY, Li XG, Zhang R, Li N, Yao HW.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):378-81. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.014. Chinese.

PMID:
22883461
19.

Abdominoperineal resection for squamous cell anal carcinoma: survival and risk factors for recurrence.

Lefèvre JH, Corte H, Tiret E, Boccara D, Chaouat M, Touboul E, Svrcek M, Lefrancois M, Shields C, Parc Y.

Ann Surg Oncol. 2012 Dec;19(13):4186-92. doi: 10.1245/s10434-012-2485-1. Epub 2012 Jul 24.

PMID:
22825769
20.

Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer.

Jeon W, Koh HK, Kim HJ, Wu HG, Kim JH, Chung HH.

J Gynecol Oncol. 2012 Jul;23(3):168-74. doi: 10.3802/jgo.2012.23.3.168. Epub 2012 Jul 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk